Melphalan hydrochloride and Celexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Melphalan hydrochloride (melphalan hydrochloride) and Celexa (citalopram hydrobromide). Common drug interactions include hypertension among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Melphalan hydrochloride and Celexa. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Melphalan hydrochloride?

Melphalan hydrochloride has active ingredients of melphalan hydrochloride. eHealthMe is studying from 3,970 Melphalan hydrochloride users. Check the latest studies of Melphalan hydrochloride.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 15, 2026

43 people who take Melphalan hydrochloride and Celexa together, and have interactions are studied.

Melphalan hydrochloride and Celexa drug interactions.

What are the common drug interactions of Melphalan Hydrochloride and Celexa, by gender? *:

female:

  1. Hypertension (high blood pressure)
  2. Multiple myeloma (cancer of the plasma cells)
  3. Nausea (feeling of having an urge to vomit)
  4. Oedema peripheral (superficial swelling)
  5. Pain
  6. Pain in jaw
  7. Pyrexia (fever)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Fall
  10. Stem cell transplant

male:

  1. Constipation
  2. Pain
  3. Renal failure (kidney dysfunction)
  4. Tooth extraction
  5. Aortic arteriosclerosis (hardening of the aortic arteries)
  6. Back pain
  7. Myalgia (muscle pain)
  8. Nausea (feeling of having an urge to vomit)
  9. Pneumonia
  10. Anaemia (lack of blood)

What are the common drug interactions of Melphalan Hydrochloride and Celexa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Back pain
  4. Bone disorder
  5. Constipation
  6. Diarrhoea
  7. Fatigue (feeling of tiredness)
  8. Pain
  9. Abdominal pain
  10. Arthropathy

50-59:

  1. Hypertension (high blood pressure)
  2. Multiple myeloma (cancer of the plasma cells)
  3. Nausea (feeling of having an urge to vomit)
  4. Oedema peripheral (superficial swelling)
  5. Pain in jaw
  6. Pyrexia (fever)
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Fall
  9. Stem cell transplant
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

60+:

  1. Constipation
  2. Pain
  3. Aortic arteriosclerosis (hardening of the aortic arteries)
  4. Blood glucose increased
  5. Decreased interest
  6. General physical health deterioration (weak health status)
  7. Myalgia (muscle pain)
  8. Nausea (feeling of having an urge to vomit)
  9. Pyrexia (fever)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 18 people, 41.86%
  2. Pain: 12 people, 27.91%
  3. Stress And Anxiety: 10 people, 23.26%
  4. Neoplasm Malignant (cancer tumour): 9 people, 20.93%
  5. High Blood Pressure: 9 people, 20.93%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 20.93%
  7. Fatigue (feeling of tiredness): 9 people, 20.93%
  8. Nausea (feeling of having an urge to vomit): 4 people, 9.30%

* Approximation only. Some reports may have incomplete information.

Do you take Melphalan hydrochloride and Celexa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Melphalan hydrochloride and Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Melphalan hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Melphalan hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on melphalan hydrochloride and citalopram hydrobromide (the active ingredients of Melphalan hydrochloride and Celexa, respectively), and Melphalan hydrochloride and Celexa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: